-

Robbins LLP Is Investigating the Officers and Directors of Poseida Therapeutics, Inc. (PSTX) on Behalf of Shareholders

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating whether Poseida Therapeutics, Inc. (NASDAQ: PSTX) and its officers and directors violated securities laws and engaged in unlawful business practices in connection with its initial public offering ("IPO"). Poseida is a clinical-stage biopharmaceutical company that develops therapeutics for patients with high unmet medical needs.

If you have suffered a loss due to Poseida Therapeutics, Inc.'s misconduct, click here.

Poseida conducted its IPO on July 10, 2020, issuing 14 million shares for $16.00 per share. On August 18, 2020, Poseida announced that the U.S. Food and Drug Administration had placed a clinical hold on its Phase 1 clinical trial evaluating the autologous CAR-T therapy P-PSMA-101 in patients with metastatic castration-resistant prostate cancer due to a patient's death. On this news, Poseida's stock fell 30.31%, to close at $9.06 on August 18, 2020.

Poseida Therapeutics, Inc. (PSTX) Shareholders Have Legal Options

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against Poseida settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Industry:

Robbins LLP

NASDAQ:PSTX
Release Versions
English
$Cashtags
$GNUS
Hashtags
#ClassAction
#Finance
#Investment
#Investor
#Lawsuit
#Securities
#Shareholder
#Shareholderrights
#StockAlert
#StockMarketData
#StockNews
#StockTrading
#Stocks
#Trader
#shareholderrightslawfirm

Contacts

Lauren Levi
Robbins LLP
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the Gartner, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Gartner, Inc. (NYSE: IT) common stock between February 4, 2025 and February 2, 2026. Gartner is a global company that provides technology and business insights to its clientele through guidance, tools, conferences, and direct consulting. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003....

Investor Notice: Robbins LLP Informs Investors of the Grocery Outlet Holding Corp. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Grocery Outlet Holding Corp. (NASDAQ: GO) securities between August 5, 2025 and March 4, 2026. Grocery Outlet Holding Corp. operates as a retailer of consumables and fresh products sold through independently operated stores in the United States. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 35...

Investor Notice: Robbins LLP Informs Investors of the Alight, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Alight, Inc. (NYSE: ALIT) common stock between November 12, 2024 and February 18, 2026. Alight is predominantly an employee benefits solutions company that provides technology-enabled services to employees through the Alight Worklife cloud engagement platform. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a c...
Back to Newsroom